PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Aritra Mukherjee
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Peroxiredoxin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markers
Isabella Harumi Yonehara Noma
,
Larissa Anastacio da Costa Carvalho
,
Denisse Esther Mallaupoma Camarena
,
Renaira Oliveira Silva
,
Manoel Oliveira de Moraes Junior
,
Sophia Tavares de Souza
,
Julia Newton-Bishop
,
Jérémie Nsengimana
,
Silvya Stuchi Maria-Engler
August 2024
Cite
DOI
URL
Type
Journal article
Publication
Biomedicine & Pharmacotherapy
Nsengimana
Related
Immune subtyping of melanoma whole slide images using multiple instance learning
Utilising high-dimensional data in randomised clinical trials: A review of methods and practice
ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma
Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk
Defining novel causal SNPs and linked phenotypes at melanoma-associated loci
Cite
×